Mini Review - Archives of General Internal Medicine (2023) Volume 7, Issue 3
Managing Post-Traumatic Stress Disorder (PTSD) from trauma to healing.
Sobey Pietirzak *
Department of Psychiatry, Yale University, New Haven, USA
- *Corresponding Author:
- Sobey Pietirzak
Department of Psychiatry
Yale University
New Haven, USA
E-mail: sobeyp88@yale.edu
Received:27 May-2023, Manuscript No. AAAGIM-23-103434; Editor assigned:01-Jun-2023, PreQC No. AAAGIM-23-103434 (PQ); Reviewed:16-Jun-2023, QC No. AAAGIM-23-103434; Revised:19-Jun-2023, Manuscript No. AAAGIM-23-103434 (R); Published:28-Jun-2023, DOI:10.35841/ aaaa-7.3.179
Citation: Pietirzak S. Managing Post-Traumatic Stress Disorder (PTSD) from trauma to healing. Arch Gen Intern Med. 2023;7(3):179
Abstract
Post-Traumatic Stress Disorder (PTSD) is a complex psychological condition that can have a substantial influence on an individual's well-being and quality of life. This abstract looks at the process of dealing with PTSD, from the original trauma to the route of healing and recovery. The abstract opens by emphasising the tremendous influence of trauma on the development of PTSD, focusing on the various sorts of traumatic events that might cause the illness. It delves into the symptoms and expressions of PTSD, offering light on the emotional, cognitive, and physiological impacts that people may encounter. The abstract also dives into the difficulties that people living with PTSD encounter, such as the disruptions it can bring in numerous aspects of their lives, such as job, relationships, and overall functioning.
Abstract
Post-Traumatic Stress Disorder (PTSD) is a complex psychological condition that can have a substantial influence on an individual's well-being and quality of life. This abstract looks at the process of dealing with PTSD, from the original trauma to the route of healing and recovery. The abstract opens by emphasising the tremendous influence of trauma on the development of PTSD, focusing on the various sorts of traumatic events that might cause the illness. It delves into the symptoms and expressions of PTSD, offering light on the emotional, cognitive, and physiological impacts that people may encounter. The abstract also dives into the difficulties that people living with PTSD encounter, such as the disruptions it can bring in numerous aspects of their lives, such as job, relationships, and overall functioning.
Key words
Post-Traumatic Stress Disorder (PTSD), Physiopathological, Prazosin, Selective Serotonin Reuptake Inhibitor (SSRI), Sertralin.
Introduction
The stress caused by traumatic experiences causes a variety of psycho-emotional and physiopathological effects. Post-traumatic stress disorder (PTSD) is a psychiatric illness caused by witnessing or experiencing traumatic or life-threatening events. PTSD has significant psychobiological connections that can interfere with daily living and be life threatening. Given contemporary events (e.g., lengthy combat, terrorism, and exposure to specific environmental chemicals), a significant increase in PTSD diagnoses is projected over the next decade. PTSD is a severe public health concern, necessitating the pursuit of novel paradigms and theoretical models in order to deepen understanding of the illness and develop new and improved forms of treatment intervention [1].
Subjects suffering from PTSD frequently relive the trauma through nightmares and flashbacks. They report sleeping difficulties. Their behaviour becomes progressively alienated or estranged, which is typically exacerbated by other diseases such as depression, substance addiction, and memory and cognition issues. The condition quickly impairs the ability to operate in social or family life, which frequently results in occupational instability, marital troubles and divorces, family discord, and parenting challenges. The disorder can be severe enough and last long enough to interfere with a person's everyday life and, in extreme cases, lead to suicidal thoughts. PTSD is distinguished by clear physiologic changes, in addition to the psychological symptoms mentioned above, and is thus complicated by a range of factors [2].
Drug treatment for PTSD tries to repair neurotransmitter and neuroendocrine system dysfunctions, as well as functional neuroanatomical abnormalities thought to play a role in developing and/or exacerbating persistent symptoms. The recovery of PTSD sufferers is difficult, and the treatment plan chosen is critical. For PTSD, clinical recommendations advised selective serotonin reuptake inhibitors (SSRIs; for example, fluoxetine, paroxetine, and sertraline) and selective serotonin-norepinephrine reuptake inhibitors (SNRIs; for example, venlafaxine). The Veterans Affairs Office of Research and Development PTSD Psychopharmacology Working Group recently called the limited psychopharmacological treatment options for PTSD a "crisis." Only two SSRIs, sertraline and paroxetine, have PTSD indications approved by the US Food and Drug Administration, but other large studies have shown efficacy of fluoxetine and venlafaxine for PTSD treatment [3].
Post-traumatic stress disorder treatment can assist you in regaining control of your life. The primary treatment is psychotherapy, however medicines may also be used. Combining these remedies can help improve your symptoms by doing the following: •
- Teaching you how to deal with your symptoms
- Helping you think more positively about yourself, others, and the world Learning how to manage if any symptoms recur
- Treating additional issues that are frequently associated with traumatic experiences, such as depression, anxiety, or drug or alcohol abuse
- You do not have to bear the burden of PTSD on your own [4].
The Food and Drug Administration (FDA) has approved the Selective Serotonin Reuptake Inhibitor (SSRI) drugs sertraline (Zoloft) and paroxetine (Paxil) for the treatment of PTSD. These drugs can help with depression and anxiety symptoms. They can also aid with sleep issues and attention. While multiple studies have suggested that prazosin (Minipress) may lessen or suppress nightmares in some PTSD patients, a more recent research found no advantage above placebo. However, participants in the recent study differed from others in ways that could have an impact on the results. Individuals seeking prazosin should consult with a doctor to evaluate whether their specific circumstance warrants a trial of this medication [5].
Conclusion
At last, transitioning from trauma to healing requires a holistic and individualised strategy. This process requires early intervention, accurate diagnosis, evidence-based therapy, and on-going support systems. We can help those impacted by PTSD regain their lives and move forward by providing compassion, understanding, and access to proven treatments. We can build hope, resilience, and healing for people traversing the route from trauma to recovery by working together.
References
- Griffin MG, Uhlmansiek MH, Resick PA, et al. Comparison of the posttraumatic stress disorder scale versus the clinician?administered posttraumatic stress disorder scale in domestic violence survivors. Trauma Stress. 2004;17(6):497-503.
- Brunet A, Weiss DS, Metzler TJ, et al. The Peritraumatic Distress Inventory: a proposed measure of PTSD criterion A2. Am J Psychiatry. 2001;158(9):1480-5.
- Foa EB, Cashman L, Jaycox L, et al. The validation of a self-report measure of posttraumatic stress disorder: the Posttraumatic Diagnostic Scale. Psychol Assess. 1997;9(4):445.
- Kim MJ, Chey J, Chung A, et al. Diminished rostral anterior cingulate activity in response to threat-related events in posttraumatic stress disorder . J Psychiatr Res. 2008;42(4):268-77.
- Sherman JJ. Effects of psychotherapeutic treatments for PTSD: A meta?analysis of controlled clinical trials. J Trauma Stress. 1998;11(3):413-35.
Indexed at, Google Scholar,Cross Ref
Indexed at, Google Scholar,Cross Ref
Indexed at, Google Scholar, Cross Ref